Search Results 101-110 of 16266 for monoclonal antibody

  1. Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients (IMAGINE) - Mayo Clinic

    About this study. The purpose of this study is to investigate whether clazakizumab (an anti-interleukin (IL)-6 monoclonal antibody (mAb)) may be beneficial ...

  2. Dinutuximab (intravenous route) - Mayo Clinic

    This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

  3. Drug to prevent RSV in babies approved: What you need to know - Mayo Clinic News Network

    The medication, given as a single-dose injection prior to or during RSV season, is a monoclonal antibody. It is intended for babies born during or entering ...

  4. Melphalan flufenamide (intravenous route) - Mayo Clinic

    ... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. Melphalan flufenamide belongs to the group of medicines ...

  5. Strategy for Improving Stroke Treatment Response - Mayo Clinic

    The purpose of this study is to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in ...

  6. Potential one-time gene therapy treatment for wet age-related macular degeneration - Mayo Clinic

    ... monoclonal antibody fragment," says Dr. Bakri. "The expressed protein is designed to neutralize vascular endothelial growth factor (VEGF) activity. Anti ...

  7. Neuromyelitis optica - Diagnosis and treatment - Mayo Clinic

    A health care provider might test the blood for the aquaporin-4-immunoglobulin G, also called AQP4-IgG antibody. ... Monoclonal antibodies have been shown in ...

  8. Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic

    ... monoclonal antibody therapy prior to anti-EGFR monoclonal antibody therapy. For those with left-sided tumors, the data are less clear. However, we at least ...

  9. A Safety and Efficacy Study of Domvanalimab + Zimberelimab Combination Therapy in Participants With Advanced Upper Gastrointestinal Tract Malignancies - Mayo Clinic

    ... monoclonal antibody domvanalimab, the anti-programmed cell death protein 1 (PD-1) monoclonal antibody zimberelimab, and multiagent chemotherapy in the first ...

  10. Publications - Mike M. Bierle, M.D. - Mayo Clinic

    ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Yang J, Shin KM, Do A, Bierle ...